Question: is this a 2) strong advice, 1) weak advice 0) no advice?

LDL-C levels\xa0<25 or\xa0<15 mg/dl on alirocumab were not associated with an increase in overall treatment-emergent adverse event rates or neurocognitive events, although cataract incidence appeared to be\xa0increased\xa0in the group achieving LDL-C levels\xa0<25 mg/dl.
user
This is no advice
assistant